DNA interchain cross-links formed by acrolein and crotonaldehyde

被引:155
作者
Kozekov, ID
Nechev, LV
Moseley, MS
Harris, CM
Rizzo, CJ
Stone, MP
Harris, TM
机构
[1] Vanderbilt Univ, Dept Chem, Nashville, TN 37235 USA
[2] Vanderbilt Univ, Ctr Mol Toxicol, Nashville, TN 37235 USA
关键词
D O I
10.1021/ja020778f
中图分类号
O6 [化学];
学科分类号
0703 ;
摘要
Acrolein and higher alpha,beta-unsaturated aldehydes are bifunctional genotoxins. The deoxyguanosine adduct of acrolein, 3-(2-deoxy-beta-D-erythro-pentofuranosyl)-5,6,7,8-tetrahydro-8-hydroxypyrimido[1,2-a]purin-10(3H)-one (8-hydroxy-1,N-2-propanodeoxyguanosine, 2a), is a major DNA adduct formed by acrolein. The potential for oligodeoxynucleotide duplexes containing 2a to form interchain cross-links was evaluated by HPLC, CZE, MALDI-TOF, and melting phenomena. Interchain cross-links represent one of the most serious types of damage in DNA since they are absolute blocks to replication. In oligodeoxynucleotides containing the sequence 5'-dC-2a, cross-linking occurred in a slow, reversible manner to the extent of similar to50%. Enzymatic digestion to form 3-(2-deoxy-beta-D-erythro-pentofuranosyl)-5,6,7,8-tetrahydro-8-(N-2-2'-deoxyguanosinyl)pyrimido[1,2-a]purin-10(3H)one (5a) and reduction with NaCNBH3 followed by enzymatic digestion to give 1,3-bis(2'-deoxyguanosin-N-2-yl)propane (6a) established that cross-linking had occurred with the exocyclic amino group of deoxyguanosine. It is concluded that the cross-link is a mixture of imine and carbinolamine structures. With oligodeoxynucleotide duplexes containing the sequence 5'-2a-dC, cross-links were not detected by the techniques enumerated above. In addition, N-15-H-1 HSQC and HSOC-filtered NOESY spectra carried out with a duplex having N-15-labeling of the target amino group established unambiguously that a carbinolamine cross-link was not formed. The potential for interchain cross-link formation by the analogous crotonaldehyde adduct (2b) was evaluated in a 5'-dC-2b sequence. Cross-link formation was strongly dependent on the configuration of the methyl group at C6 of 2b. The 6R diastereomer of 2b formed a cross-link to the extent of 38%, whereas the 6S diastereomer cross-linked only 5%.
引用
收藏
页码:50 / 61
页数:12
相关论文
共 46 条
[1]   Evidence for a recombination-independent pathway for the repair of DNA interstrand cross-links based on a site-specific study with nitrogen mustard [J].
Berardini, M ;
Mackay, W ;
Loechler, EL .
BIOCHEMISTRY, 1997, 36 (12) :3506-3513
[2]  
BORER PN, 1975, HDB BIOCH MOL BIOL, P359
[3]   RECOGNITION BETWEEN MITOMYCIN-C AND SPECIFIC DNA-SEQUENCES FOR CROSS-LINK FORMATION [J].
BOROWYBOROWSKI, H ;
LIPMAN, R ;
TOMASZ, M .
BIOCHEMISTRY, 1990, 29 (12) :2999-3006
[4]  
CHUNG FL, 1983, CANCER RES, V43, P1230
[5]   Endogenous formation and significance of 1,N2-propanodeoxyguanosine adducts [J].
Chung, FL ;
Nath, RG ;
Nagao, M ;
Nishikawa, A ;
Zhou, GD ;
Randerath, K .
MUTATION RESEARCH-FUNDAMENTAL AND MOLECULAR MECHANISMS OF MUTAGENESIS, 1999, 424 (1-2) :71-81
[6]  
CHUNG FL, 1984, CANCER RES, V44, P990
[7]   DETECTION OF CYCLIC 1,N-2-PROPANODEOXYGUANOSINE ADDUCTS IN DNA OF RATS TREATED WITH N-NITROSOPYRROLIDINE AND MICE TREATED WITH CROTONALDEHYDE [J].
CHUNG, FL ;
YOUNG, R ;
HECHT, SS .
CARCINOGENESIS, 1989, 10 (07) :1291-1297
[8]   NMR characterization of a DNA duplex containing the major acrolein-derived deoxyguanosine adduct γ-OH-1,N2-propano-2′-deoxyguanosine [J].
de los Santos, C ;
Zaliznyak, T ;
Johnson, F .
JOURNAL OF BIOLOGICAL CHEMISTRY, 2001, 276 (12) :9077-9082
[9]   Improved strategies for postoligomerization synthesis of oligodeoxynucleotides bearing structurally defined adducts at the N-2 position of deoxyguanosine [J].
DeCorte, BL ;
Tsarouhtsis, D ;
Kuchimanchi, S ;
Cooper, MD ;
Horton, P ;
Harris, CM ;
Harris, TM .
CHEMICAL RESEARCH IN TOXICOLOGY, 1996, 9 (03) :630-637
[10]   Multiple DNA repair mechanisms and alkylator resistance in the human medulloblastoma cell line D-283 Med (4-HCR) [J].
Dong, Q ;
Johnson, SP ;
Colvin, OM ;
Bullock, N ;
Kilborn, C ;
Runyon, G ;
Sullivan, DM ;
Easton, J ;
Bigner, DD ;
Nahta, R ;
Marks, J ;
Modrich, P ;
Friedman, HS .
CANCER CHEMOTHERAPY AND PHARMACOLOGY, 1999, 43 (01) :73-79